Cero Therapeutics Holdings ICERO
13F holders, Q2 2025 (June 30)8holders
$9.63avg. 13F price*
At the end of Q2 2025, 8 institutions reported holding Cero Therapeutics Holdings I (CERO) in their 13F filings. The largest holders were Parallel Advisors, LLC ($2.1M), ARCH Venture Management, LLC ($216K) and UBS Group AG ($25K).
- Company
- Cero Therapeutics Holdings I
- CUSIP
- 71902K402
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $2.4M |
| Exits | 0 | $0 |
Ownership 8 holders
| Parallel Advisors, LLC | 0.04% | New | 220,000 | $2.1M |
| ARCH Venture Management, LLC | 0.07% | New | 22,389 | $216K |
| UBS Group AG | 0.00% | New | 2,625 | $25K |
| FNY Investment Advisers, LLC | 0.00% | New | 1,050 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 684 | $7K |
| SBI Securities Co., Ltd. | 0.00% | New | 18 | $173 |
| Jones Financial Companies LLLP | 0.00% | New | 3 | $29 |
| Bank of America Corp. | 0.00% | New | 2 | $19 |
"% of holder's portfolio" is CERO's weight in each manager's 13F, not the share of Cero Therapeutics Holdings I the manager owns.